CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Berlin-zehlendorf, Germany

< 2 Miles
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
  • Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

    Phase

    3

    Span

    201 weeks

    Sponsor

    Anthos Therapeutics, Inc.

    Ramos Mejia

    Recruiting

  • A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

    Phase

    3

    Span

    470 weeks

    Sponsor

    Akero Therapeutics, Inc

    Ramos Mejia, Buenos Aires

    Recruiting

  • A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

    Phase

    3

    Span

    269 weeks

    Sponsor

    Akero Therapeutics, Inc

    Ramos Mejia, Buenos Aires

    Recruiting

  • A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

    Phase

    1

    Span

    338 weeks

    Sponsor

    GlaxoSmithKline

    Ciudadela

    Recruiting

  • A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

    Phase

    3

    Span

    205 weeks

    Sponsor

    Boehringer Ingelheim

    Ciudadela

    Recruiting

1-5 of 5
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 609.945.0101

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information